BK
Bipin Kumar
About Bipin Kumar
Data last updated:
Bipin Kumar is a Director at Alvis Biotech India Private Limited (since 2021) and Director at Kalite Pharmaceuticals Private Limited (since 2021). The companies operate in Trading. The largest current company by reported revenue is Alvis Biotech India Private Limited at ₹1.8 Lakh (FY 2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Alvis Biotech India Private Limited U74999UR2015PTC001573 | Director | 09 Apr 2021 | 2015 | ₹1.8 Lakh (FY 2017) | Active |
| Kalite Pharmaceuticals Private Limited U51909DL2015PTC279920 | Director | 20 Mar 2021 | 2015 | Active |
Board colleagues of Bipin Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Arun Kumar Sinha | 05163688 | Alvis Biotech India Private Limited , Kalite Pharmaceuticals Private Limited | Director |
| Sharmila Mahato | 09032433 | Alvis Biotech India Private Limited | Whole-Time Director |
| Shrestha Srivastava | 11456100 | Alvis Biotech India Private Limited | Whole-Time Director |
| Alok Kumar Singh | 09169595 | Kalite Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bipin Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bipin Kumar
Bipin Kumar currently holds 2 directorships: Alvis Biotech India Private Limited (Director, since 09 Apr 2021, revenue ₹1.8 Lakh (FY 2017)); Kalite Pharmaceuticals Private Limited (Director, since 20 Mar 2021).
Bipin Kumar was first appointed on 20 Mar 2021 as Director at Kalite Pharmaceuticals Private Limited.
The current boards of Bipin Kumar's companies include Arun Kumar Sinha (Alvis Biotech India Private Limited), Sharmila Mahato (Alvis Biotech India Private Limited), Shrestha Srivastava (Alvis Biotech India Private Limited), Alok Kumar Singh (Kalite Pharmaceuticals Private Limited).